First-Line Treatment Induced With mFOLFOX6 and HLX04 Regimen, Following Combined With Serplulimab in MSS Initially Unresectable Metastatic Colorectal Cancer

Clinical trial NCT06491355 · UNKNOWN

Trial details

NCT number: NCT06491355
Sponsor: Sir Run Run Shaw Hospital
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Efficacy, Self Safety Issues Colo-rectal Cancer

Start date: 2024-07-01
Primary completion: 2025-06-30
Enrollment: 72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.